Ruxolitinib 11014-0452
Product NDC
11014-0452- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Tablet
- Product Type
- Drug For Further Processing
- Marketing Start
- November 16, 2011
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ruxolitinib | 20 mg/1 |
Packaging Options(1)
1 BAG in 1 DRUM (11014-0452-2) / 20000 TABLET in 1 BAG